Literature DB >> 4008345

The structure of streptonigrone, and a comment on the biosynthesis of the streptonigrin antibiotics.

A J Herlt, R W Rickards, J P Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4008345     DOI： 10.7164/antibiotics.38.516

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

1.  Shikimic acid: review of its analytical, isolation, and purification techniques from plant and microbial sources.

Authors:  Denis V Bochkov; Sergey V Sysolyatin; Alexander I Kalashnikov; Irina A Surmacheva
Journal:  J Chem Biol       Date:  2011-07-24

2.  Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones.

Authors:  Mohammad Behforouz; Wen Cai; Farahnaz Mohammadi; Mark G Stocksdale; Zhengxiang Gu; Mohammad Ahmadian; Darric E Baty; Michele R Etling; Charmaine H Al-Anzi; Tyson M Swiftney; Lee R Tanzer; Ronald L Merriman; Nancy C Behforouz
Journal:  Bioorg Med Chem       Date:  2006-10-10       Impact factor: 3.641

Review 3.  5,8-Quinolinedione Scaffold as a Promising Moiety of Bioactive Agents.

Authors:  Monika Kadela-Tomanek; Ewa Bębenek; Elwira Chrobak; Stanisław Boryczka
Journal:  Molecules       Date:  2019-11-14       Impact factor: 4.411

4.  Total synthesis of the antitumor antibiotic (±)-streptonigrin: first- and second-generation routes for de novo pyridine formation using ring-closing metathesis.

Authors:  Timothy J Donohoe; Christopher R Jones; Anne F Kornahrens; Luiz C A Barbosa; Louise J Walport; Matthew R Tatton; Michael O'Hagan; Akshat H Rathi; David B Baker
Journal:  J Org Chem       Date:  2013-12-12       Impact factor: 4.354

5.  Identification of (2S,3S)-β-Methyltryptophan as the Real Biosynthetic Intermediate of Antitumor Agent Streptonigrin.

Authors:  Dekun Kong; Yi Zou; Zhang Zhang; Fei Xu; Nelson L Brock; Liping Zhang; Zixin Deng; Shuangjun Lin
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.